There is no fulltext present in this item.

Find Full text  
Title: Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
Author(s): Gorcenco, S.; Vaz, F.M.; Siemiatkowska, A.M.; Tranebjaerg, L.; Cremers, F.P.M. ; Ygland, E.; Kicsi, J.; Rendtorff, N.D.; Moller, C.; Kjellstrom, U.; Andreasson, S.; Puschmann, A.
Publication year: 2019
Source: Parkinsonism & Related Disorders, vol. 61, (2019), pp. 245-247
ISSN: 1353-8020
DOI: https://doi.org/10.1016/j.parkreldis.2018.10.017
Publication type: Article / Letter to editor

Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/206709   https://hdl.handle.net/2066/206709

Display more details
Subject: Radboudumc 12: Sensory disorders DCMN: Donders Center for Medical Neuroscience
Organization: Human Genetics
Journal title:
Parkinsonism & Related Disorders
Volume: vol. 61
Page start: p. 245
Page end: p. 247

This item appears in the following Collection(s)

Browse

Statistics